drugset / Trial / NCT00098111
Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease
RandomizedParallel-groupTriple-blind
Summary
The purpose of this study is to identify an optimal weight based dose of azathioprine that is safe and effective in the treatment of subjects with active Crohn's disease requiring treatment with corticosteroids, and for maintaining remission in those subjects.
Timeline
- Start
- 2005-04
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azathioprine | Small molecule | 0.5 mg/kg | — |
| Comparator | Azathioprine | Small molecule | 2.5 mg/kg | — |
| Comparator | Azathioprine | Small molecule | 3.5 mg/kg | — |